Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 3, 2010, Pages 439-449

  Lodish, Maya B ^a   Stratakis, Constantine A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cowden; mammalian target of rapamycin; neuroendocrine tumours; Peutz Jegher; phakomatoses; tumour suppressor

Indexed keywords

BEVACIZUMAB; ERLOTINIB; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NEUROFIBROMIN; OCTREOTIDE; PASIREOTIDE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAPAMYCIN; SORAFENIB; TEMOZOLOMIDE; TEMSIROLIMUS; TIPIFARNIB;

ACROMEGALY; CANCER EPIDEMIOLOGY; CLINICAL TRIAL; COWDEN SYNDROME; DISEASE SURVEILLANCE; DUODENUM TUMOR; ENDOCRINE TUMOR; GASTROINTESTINAL POLYPOSIS; GASTROINTESTINAL STROMAL TUMOR; GLIOMA; HUMAN; NEUROFIBROMA; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; PHEOCHROMOCYTOMA; REVIEW; SOMATISTONOMA; TUBEROUS SCLEROSIS;

ENDOCRINE GLAND NEOPLASMS; HUMANS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS;

EID: 77956604638     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.02.002     Document Type: Review

References (86)

1. S.A. Rasmussen, and J.M. Friedman NF1 gene and neurofibromatosis 1 American Journal of Epidemiology 151 1 2000 Jan 1 33 40
2. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference Archives of Neurology 45 5 1988 May 575 578
3. K. DeBella, J. Szudek, and J.M. Friedman Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children Pediatrics 105 3 Pt 1 2000 Mar 608 614 (Pubitemid 30129679)
4. D.H. Gutmann, A. Aylsworth, and J.C. Carey The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 The Journal of the American Medical Association 278 1 1997 Jul 2 51 57
5. S.A. Sorensen, J.J. Mulvihill, and A. Nielsen Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms The New England Journal of Medicine 314 16 1986 Apr 17 1010 1015
6. L. Walker, D. Thompson, and D. Easton A prospective study of neurofibromatosis type 1 cancer incidence in the UK British Journal of Cancer 95 2 2006 Jul 17 233 238 (Pubitemid 44050923)
7. N. Alexakis, S. Connor, and P. Ghaneh Hereditary pancreatic endocrine tumours Pancreatology 4 5 2004 417 433 discussion 34-5
8. M. Miettinen, J.F. Fetsch, and L.H. Sobin Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases The American Journal of Surgical Pathology 30 1 2006 Jan 90 96
9. M.E. Zoller, B. Rembeck, and A. Oden Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population Cancer 79 11 1997 Jun 1 2125 2131
10. C. Mussi, H.U. Schildhaus, and A. Gronchi Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1 Clinical Cancer Research 14 14 2008 Jul 15 4550 4555
11. T. Zelinka, G. Eisenhofer, and K. Pacak Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice Stress 10 2 2007 Jun 195 203
12. C.G. Toumpanakis, and M.E. Caplin Molecular genetics of gastroenteropancreatic neuroendocrine tumors The American Journal of Gastroenterology 103 3 2008 Mar 729 732
13. M.M. Walther, J. Herring, and E. Enquist von Recklinghausen's disease and pheochromocytomas The Journal of Urology 162 5 1999 Nov 1582 1586
14. Y. Dayal, K.A. Tallberg, and G. Nunnemacher Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study The American Journal of Surgical Pathology 10 5 1986 May 348 357
15. C. Mao, A. Shah, and D.J. Hanson Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas Journal of Surgical Oncology 59 1 1995 May 67 73
16. M. Anlauf, N. Garbrecht, and J. Bauersfeld Hereditary neuroendocrine tumors of the gastroenteropancreatic system Virchows Archiv 451 Suppl. 1 2007 Aug S29 S38
17. R.T. Jensen, M.J. Berna, and D.B. Bingham Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies Cancer 113 7 Suppl. 2008 Oct 1 1807 1843
18. R. Caiazzo, C. Mariette, and G. Piessen Type I neurofibromatosis, pheochromocytoma and somatostatinoma of the ampulla. Literature review Annales de chirurgie 131 6-7 2006 Jul-Aug 393 397
19. C. Cappelli, B. Agosti, and M. Braga Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature Minerva Endocrinologica 29 1 2004 Mar 19 24
20. W.S. Lee, Y.S. Koh, and J.C. Kim Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report BMC Cancer 5 2005 85
21. J.P. Chagnon, J. Barge, and D. Henin Recklinghausen's disease with digestive localizations associated with gastric acid hypersecretion suggesting Zollinger-Ellison syndrome Gastroentérologie clinique et biologique 9 1 1985 Jan 65 69
22. A. Perren, P. Wiesli, and S. Schmid Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient The American Journal of Surgical Pathology 30 8 2006 Aug 1047 1051
23. R.L. Coskey, and R.E. Tranquada Insulinoma and Multiple Neurofibromatosis: report of a case Metabolism 13 1964 Apr 312 318
24. R.A. Lewis, L.P. Gerson, and K.A. Axelson von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata Ophthalmology 91 8 1984 Aug 929 935
25. R. Listernick, R.E. Ferner, and G.T. Liu Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations Annals of Neurology 61 3 2007 Mar 189 198
26. J.H. Hersh Health supervision for children with neurofibromatosis Pediatrics 121 3 2008 Mar 633 642
27. R.M. Cawthon, R. Weiss, and G.F. Xu A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations Cell 62 1 1990 Jul 13 193 201
28. M.R. Wallace, D.A. Marchuk, and L.B. Andersen Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients Science 249 4965 1990 Jul 13 181 186
29. G.A. Martin, D. Viskochil, and G. Bollag The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 Cell 63 4 1990 Nov 16 843 849
30. H. Brems, E. Beert, and T. de Ravel Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 The Lancet Oncology 10 5 2009 May 508 515
31. M. Rosner, M. Hanneder, and N. Siegel The mTOR pathway and its role in human genetic diseases Mutation Research 659 3 2008 Sep-Oct 284 292
32. D.J. Kwiatkowski, and B.D. Manning Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways Human Molecular Genetics 14 Spec No. 2 2005 Oct 15 R251 R258
33. D.K. Sandsmark, C. Pelletier, and J.D. Weber Mammalian target of rapamycin: master regulator of cell growth in the nervous system Histology and Histopathology 22 8 2007 Aug 895 903
34. C.M. Johannessen, E.E. Reczek, and M.F. James The NF1 tumor suppressor critically regulates TSC2 and mTOR Proceedings of the National Academy of Sciences of the United States of America 102 24 2005 Jun 14 8573 8578
35. J.J. Mulvihill, D.M. Parry, and J.L. Sherman NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update Annals of Internal Medicine 113 1 1990 Jul 1 39 52
36. D. Viskochil, A.M. Buchberg, and G. Xu Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus Cell 62 1 1990 Jul 13 187 192
37. B.C. Widemann, W.L. Salzer, and R.J. Arceci Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas Journal of Clinical Oncology 24 3 2006 Jan 20 507 516
38. J.P. Osborne, A. Fryer, and D. Webb Epidemiology of tuberous sclerosis Annals of the New York Academy of Sciences 615 1991 125 127
39. T. Rosser, A. Panigrahy, and W. McClintock The diverse clinical manifestations of tuberous sclerosis complex: a review Seminars in Pediatric Neurology 13 1 2006 Mar 27 36
40. E.S. Roach, M.R. Gomez, and H. Northrup Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria Journal of Child Neurology 13 12 1998 Dec 624 628
41. E.S. Roach, F.J. DiMario, and R.S. Kandt Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association Journal of Child Neurology 14 6 1999 Jun 401 407
42. S.A. Narod, C. Stiller, and G.M. Lenoir An estimate of the heritable fraction of childhood cancer British Journal of Cancer 63 6 1991 Jun 993 999
43. D. Dworakowska, and A.B. Grossman Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review Endocrine-Related Cancer 16 1 2009 Mar 45 58
44. S. Tigas, P.V. Carroll, and R. Jones Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny Clinical Endocrinology 63 6 2005 Dec 694 695
45. R. Nandagopal, A. Vortmeyer, and E.H. Oldfield Cushing's syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: an association or a coincidence? Clinical Endocrinology 67 4 2007 Oct 639 641
46. W.H. Hoffman, J.C. Perrin, and E. Halac Acromegalic gigantism and tuberous sclerosis The Journal of Pediatrics 93 3 1978 Sep 478 480
47. Z.T. Bloomgarden, G.W. McLean, and D. Rabin Autonomous hyperprolactinemia in tuberous sclerosis Archives of Internal Medicine 141 11 1981 Oct 1513 1515
48. L.S. Mortensen, and J. Rungby Tuberous sclerosis and parathyroid adenoma Journal of Clinical Pathology 44 11 1991 Nov 961 962
49. E.B. Ilgren, and D. Westmoreland Tuberous sclerosis: unusual associations in four cases Journal of Clinical Pathology 37 3 1984 Mar 272 278
50. W. Yin, D.M. Zhu, and D.S. Wang Parathyroid adenoma with primary hyperparathyroidism and tuberous sclerosis. A case report Chinese Medical Journal 97 8 1984 Aug 599 602
51. P.M. Davoren, and M.T. Epstein Insulinoma complicating tuberous sclerosis Journal of Neurology, Neurosurgery, and Psychiatry 55 12 1992 Dec 1209
52. N.E. Boubaddi, Y. Imbert, and B. Tissot Secreting insulinoma and Bourneville's tuberous sclerosis Gastroentérologie clinique et biologique. 21 4 1997 343
53. M.S. Eledrisi, C.A. Stuart, and M. Alshanti Insulinoma in a patient with tuberous sclerosis: is there an association? Endocrine Practice 8 2 2002 Mar-Apr 109 112
54. G. Schwarzkopf, and J. Pfisterer Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence? Zentralblatt für Pathologie 139 6 1994 Feb 477 481
55. J.L. Merritt 2nd, D.M. Davis, and M.R. Pittelkow Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations American Journal of Medical Genetics. Part A 140 15 2006 Aug 1 1669 1672
56. P. Francalanci, F. Diomedi-Camassei, and C. Purificato Malignant pancreatic endocrine tumor in a child with tuberous sclerosis The American Journal of Surgical Pathology 27 10 2003 Oct 1386 1389
57. H. Kim, A. Kerr, and H. Morehouse The association between tuberous sclerosis and insulinoma AJNR. American Journal of Neuroradiology 16 7 1995 Aug 1543 1544
58. S. Verhoef, R. van Diemen-Steenvoorde, and W.L. Akkersdijk Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood European Journal of Pediatrics 158 4 1999 Apr 284 287
59. A. Gutman, and M. Leffkowitz Tuberous sclerosis associated with spontaneous hypoglycaemia British Medical Journal 2 5159 1959 Nov 21 1065 1068
60. T. Sato, K. Seyama, and T. Kumasaka A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis Journal of Internal Medicine 256 2 2004 Aug 166 173
61. J. Stern, A. Friesen, and R. Bowering Multiple bilateral angiomyolipomas of the kidneys in tuberous brain sclerosis in association with pleomorphous pheochromocytoma Fortschritte der Medizin 100 39 1982 Oct 21 1809 1812
62. E.S. Roach, and S.P. Sparagana Diagnosis of tuberous sclerosis complex Journal of Child Neurology 19 9 2004 Sep 643 649
63. M. van Slegtenhorst, R. de Hoogt, and C. Hermans Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 Science 277 5327 1997 Aug 8 805 808 (Pubitemid 27366729)
64. R.F. Lamb, C. Roy, and T.J. Diefenbach The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho Nature Cell Biology 2 5 2000 May 281 287
65. R. Wienecke, A. Konig, and J.E. DeClue Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity The Journal of Biological Chemistry 270 27 1995 Jul 7 16409 16414
66. Identification and characterization of the tuberous sclerosis gene on chromosome 16 Cell 75 7 1993 Dec 31 1305 1315
67. A.R. Tee, D.C. Fingar, and B.D. Manning Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling Proceedings of the National Academy of Sciences of the United States of America 99 21 2002 Oct 15 13571 13576
68. C. Carbonara, L. Longa, and E. Grosso 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene Human Molecular Genetics 3 10 1994 Oct 1829 1832
69. A.J. Green, M. Smith, and J.R. Yates Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients Nature Genetics 6 2 1994 Feb 193 196
70. B.D. Manning, A.R. Tee, and M.N. Logsdon Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway Molecular Cell 10 1 2002 Jul 151 162
71. I. Ewing, S. Pedder-Smith, and G. Franchi A mutation and expression analysis of the oncogene BRAF in pituitary adenomas Clinical Endocrinology 66 3 2007 Mar 348 352
72. M. Musat, M. Korbonits, and B. Kola Enhanced protein kinase B/Akt signalling in pituitary tumours Endocrine-Related Cancer 12 2 2005 Jun 423 433
73. M.W. Johnson, C. Kerfoot, and T. Bushnell Hamartin and tuberin expression in human tissues Modern Pathology 14 3 2001 Mar 202 210
74. N. El-Hashemite, H. Zhang, and E.P. Henske Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma Lancet 361 9366 2003 Apr 19 1348 1349
75. J.J. Bissler, F.X. McCormack, and L.R. Young Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis The New England Journal of Medicine 358 2 2008 Jan 10 140 151
76. C. Lam, E. Bouffet, and U. Tabori Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors Pediatric Blood & Cancer 2009 Oct 23
77. M.R. Druce, G.A. Kaltsas, and M. Fraenkel Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001) Hormone and Metabolic Research 41 9 2009 Sep 697 702
78. B.M. Wolpin, A.F. Hezel, and T. Abrams Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer Journal of Clinical Oncology 27 2 2009 Jan 10 193 198
79. C. Eng PTEN: one gene, many syndromes Human Mutation 22 3 2003 Sep 183 198
80. C.A. Stratakis, L.S. Kirschner, and S.E. Taymans Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci The Journal of Clinical Endocrinology and Metabolism 83 8 1998 Aug 2972 2976
81. V. Nose Familial non-medullary thyroid carcinoma: an update Endocrine Pathology 19 4 2008 Winter 226 240
82. G.M. Blumenthal, and P.A. Dennis PTEN hamartoma tumor syndromes European Journal of Human Genetics 16 11 2008 Nov 1289 1300
83. C. Eng Will the real Cowden syndrome please stand up: revised diagnostic criteria Journal of Medical Genetics 37 11 2000 Nov 828 830
84. N. Hearle, V. Schumacher, and F.H. Menko Frequency and spectrum of cancers in the Peutz-Jeghers syndrome Clinical Cancer Research 12 10 2006 May 15 3209 3215
85. C.A. Stratakis Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes Frontiers in Bioscience 5 2000 Mar 1 D353 D366
86. L. Winterfield, J. Schultz, and C.A. Stratakis Gynecomastia and mucosal lentigines in an 8-year-old boy Journal of the American Academy of Dermatology 53 4 2005 Oct 660 662